Shaji K Kumar, MD¹, Melissa Alsina, MD**², Betsy Laplant, MS^3*, Ashraf Z. Badros, MD⁴, Al-Ola Abdallah, MD⁵, Rafat Abonour, MD⁶, Erik J Asmus^7*, Binod Dhakal, MBBS⁸, Cara A. Rosenbaum, MD^9*, Daniel Egan, MD^10*, Manisha Bhutani, MD¹¹, Andrzej Jakubowiak, MD, PhD¹² and Brian G.M. Durie, MD¹³

¹Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
²Moffitt Cancer Center, Tampa, FL
³Division of Clinical Trials & Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁴Greenbaum Cancer Center, University of Maryland, Baltimore, MD
⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
⁶Indiana Cancer Pavilion, Indianapolis, IN
⁷Biomedical Statistics and Informatics, Mayo Clinic, Rochester
⁸Medical College of Wisconsin, Division of Hematology/Oncology, Department of Medicine, Milwaukee, WI
⁹Weill Cornell Medicine, New York, NY
¹⁰Fred Hutchinson Cancer Research Center, Seattle, WA
¹¹Levine L. Cancer Institute, Charlotte, NC
¹²Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
¹³Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA

Martin F. Kaiser, MD, FRCP, FRCPath^1,2, Andrew Hall^3*, Isabelle Smith^3*, Ruth M. de Tute^4*, Sadie Roberts^3*, Emma Ingleson^3*, Kristian M Bowles, MBBS, PhD^5*, Mamta Garg, MD, FRCP, FRCPath^6*, Anand Lokare, MD, FRCPath, MRCP^7*, Christina Messiou, MD, BMedSci, BMBS, MRCP, FRCR^1*, Richard S. Houlston, PhD, FRS^8*, Graham Jackson, MBBS, FRCP, FRCPath, MA, DM⁹, Gordon Cook, MB ChB, PhD, FRCP(Glas), FRCPath^3*, Guy Pratt, MD FRCP FRCPath^10*, Mark T Drayson, MD^11*, Roger G Owen^12*, Sarah R Brown, PhD, MSc, BSc^3* and Matthew W Jenner^13*

¹The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom
²Myeloma Molecular Therapy Group, The Institute of Cancer Research, London, United Kingdom
³Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁴Haematological Malignancy Diagnostic Service, St. James's University Hospital, Leeds, United Kingdom
⁵Norwich Medical School, Norwich, United Kingdom
⁶University Hospital of Leicester, Leicester, United Kingdom
⁷Department of Haematology, Heartlands Hospital, University Hospitals Birmingham, Birmingham, United Kingdom
⁸Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, United Kingdom
⁹Department of Haematology, University of Newcastle, Newcastle upon Tyne, United Kingdom
¹⁰School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom
¹¹Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom
¹²HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
¹³Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

Katja C. Weisel, MD¹, Britta Besemer, MD^2*, Mathias Haenel, MD^3*, Raphael Lutz, MD^4*, Christoph Mann, MD^5*, Markus Munder, MD^6*, Martin Goerner, MD^7*, Hans Christian Reinhardt, MD⁸, Axel Nogai, MD^9*, Yon-Dschun Ko, MD^10*, Maike De Wit, MD^11*, Hans Salwender, M.D.^12*, Christoph Scheid, MD^13*, Ullrich Graeven, MD^14*, Rudolf Peceny, MD¹⁵, Peter Staib, MD^16*, Annette Dieing, MD^17*, Anna Jauch, PhD^18*, Manola Zago, PhD^19*, Axel Benner, PhD^20*, Diana Tichy, PhD^21*, Carsten Bokemeyer, MD^1*, Hartmut Goldschmidt, MD²² and Lisa B. Leypoldt^1*

¹Department of Oncology, Hematology, BMT with Section of Pneumology; University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
²Department of Hematology, Oncology, and Immunology, University of Tuebingen, Tuebingen, Germany
³Department of Hematology, Oncology and Bone Marrow Transplantation, Klinikum Chemnitz, Chemnitz, Germany
⁴Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
⁵Department of Hematology, Oncology, Immunology, University Marburg, Marburg, Germany
⁶Third Department of Medicine, University Medicine Mainz of Johannes Gutenberg University Mainz, Mainz, Germany
⁷Department of Hematology, Oncology and Palliative Medicine, Klinikum Bielefeld Mitte, Bielefeld, Germany
⁸Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
⁹Division of Hematology and Oncology at Campus Benjamin Franklin (CBF), Charité, Berlin, Germany
¹⁰Department of Internal Medicine, Hematology and Oncology, Johanniter Krankenhaus Bonn, Bonn, Germany
¹¹Vivantes Klinikum Neukoelln, Berlin, Germany
¹²Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany
¹³Leukapheresis and Stem Cell Transplant Unit, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany
¹⁴Dept. of Hematology/Oncology and Gastroenterology, Kliniken Maria Hilf GmbH, Mönchengladbach, Germany
¹⁵Klinikum Osnabruck, Osnabruck, Niedersachsen, Germany
¹⁶St. Antonius Hospital Eschweiler, Eschweiler, DEU
¹⁷Vivantes Klinikum am Urban, Berlin, Germany
¹⁸Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany
¹⁹Center for Clinical Trials, University Hospital of Tuebingen, Tuebingen, Germany
²⁰Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany
²¹Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
²²Department of Medicine V, University Clinic Heidelberg and the National Center for Tumor Diseases, Heidelberg, Germany

Morie A. Gertz, MD, MACP¹, Yuying Jin, PhD^2*, Ansgar Conrad, PhD^2* and Christie Nie, MD, MSc^2*

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Prothena Biosciences Inc., South San Francisco, CA

Efstathios Kastritis, MD^1*, Monique C. Minnema, MD, PhD², Meletios-Athanasios Dimopoulos, MD, PhD³, Giampaolo Merlini, MD⁴, Foteini Theodorakakou, MD^5*, Despina Fotiou, MD^5*, Antoine Huart, MD^6*, Karim Belhadj, MD^7*, Sreeja Varghese, PhD^8*, Kyriaki Manousou, MSc^9*, Pieter Sonneveld, MD¹⁰ and Giovanni Palladini, MD PhD¹¹

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
²Department of Hematology, University Medical Center, Utrecht, Netherlands, Utrecht, Netherlands
³Plasma Cell Dyscrasias Unit, Section of Hematology and Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁴Biotechnology Research Laboratories, Department of Molecular Medicine, Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy
⁵Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
⁶Department of Nephrology and Transplantation, HôPital Rangueil, CHU Toulouse, Toulouse, FRA
⁷Lymphoid Malignancies Department, Henri Mondor University Hospital, Creteil, France
⁸Medical Affairs, Health Data Specialists, Dublin, Ireland
⁹Health Data Specialists, Dublin, Ireland
¹⁰Department of Hematology, Erasmus MC, Rotterdam, Netherlands
¹¹Department of Molecular Medicine, Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, PV, Italy

Kwee Yong^1*, Kara-Louise Royle, MSc^2*, Karthik Ramasamy³, Christopher Parrish, MBBChir, MRCP, FRCPath, MA, PhD^4,5, Anna Hockaday^6*, Samir Asher, MRCP^7*, Mark T Drayson, MD^8*, Ruth M. de Tute^9*, Matthew W Jenner^10*, Martin F. Kaiser, MD, FRCP, FRCPath¹¹, Guy Pratt, MD FRCP FRCPath^12*, Jonathan Sive^1*, Ceri Bygrave, MD, FRCPath, MPhil^13*, Gordon Cook, MB ChB, PhD, FRCP(Glas), FRCPath^14,15*, Rakesh Popat^16*, Dean Smith^17*, Catherine Olivier^18*, Lorna Barnard^19*, Doina Levinte^19*, Bryony Dawkins, BA, MSc^20*, Michael A Chapman, PhD, MRCP, FRCPath²¹, Andrew D Chantry, PhD, MD^22*, Graham Jackson, MBBS, FRCP, FRCPath, MA, DM²³, Sergio A Quezada^24*, Roger G Owen^25* and David Cairns, PhD^26*

¹Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
²Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
³Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁴Leeds Teaching Hospitals NHS Trust, Leeds, ENG, United Kingdom
⁵Leeds Institute of Clinical Trials Research, Leesd Cancer Research UK Clinical Trials Unit, Leeds, United Kingdom
⁶Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, Leeds, United Kingdom
⁷UCL Cancer Institute, London, ENG, GBR
⁸Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom
⁹Haematological Malignancy Diagnostic Service, St. James's University Hospital, Leeds, United Kingdom
¹⁰Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
¹¹The Institute of Cancer Research, London, ENG, United Kingdom
¹²Queen Elizabeth Hospital Birmingham, WMRC, Birmingham, United Kingdom
¹³Haematology, University Hospital Wales, Cardiff, United Kingdom
¹⁴Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
¹⁵Department of Haematology, Clinical Trials Research Unit, NIHR (Leeds) IVD Cooperative, Leeds Teaching Hospital, Leeds, United Kingdom
¹⁶University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹⁷Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
¹⁸Leeds Cancer Research UK Clinical Trials Unit, Leeds, United Kingdom
¹⁹Leeds Institute of Clinical Trials Research, Leeds Cancer Research UK Clinical Trials Unit, Leeds, United Kingdom
²⁰Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom
²¹Department of Haematology, University of Cambridge, Cambridge, United Kingdom
²²Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, United Kingdom
²³Department of Haematology, NCCC Freeman Road Hospital, Newcastle Upon Tyne, United Kingdom
²⁴University College London, London, United Kingdom
²⁵St. James's University Hospital, Leeds, United Kingdom
²⁶Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, ENG, United Kingdom